- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics of COVID-19 therapies
Authors
Keywords
-
Journal
npj Genomic Medicine
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-18
DOI
10.1038/s41525-020-00143-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19: the gendered impacts of the outbreak
- (2020) Clare Wenham et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California
- (2020) Kristen M. J. Azar et al. HEALTH AFFAIRS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism
- (2020) Joris R Delanghe et al. European Journal of Preventive Cardiology
- The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues
- (2020) Behrooz Darbani International Journal of Environmental Research and Public Health
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
- (2020) Katelyn A Pastick et al. Open Forum Infectious Diseases
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Effects of host genetic variations on response to, susceptibility and severity of respiratory infections
- (2020) Soudeh Ghafouri-Fard et al. BIOMEDICINE & PHARMACOTHERAPY
- An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19
- (2020) Mostafa Saadat CLINICA CHIMICA ACTA
- Aldehyde oxidase; new approaches to old problems
- (2019) Christine Beedham XENOBIOTICA
- Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient
- (2019) Elena López Aspiroz et al. CLINICAL DRUG INVESTIGATION
- Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
- (2018) Kaarina Kowalec et al. NATURE GENETICS
- Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients
- (2018) Samya Mohammad et al. ARTHRITIS CARE & RESEARCH
- FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis
- (2018) Alberto Jiménez Morales et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications
- (2017) Hazem Elewa et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- PharmGKB summary
- (2017) Alison E. Fohner et al. Pharmacogenetics and Genomics
- Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment
- (2017) Qian-Qian Song et al. PHARMACOGENOMICS
- SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
- (2017) Vinicius A Sortica et al. PHARMACOGENOMICS
- Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
- (2016) Vincent Madelain et al. CLINICAL PHARMACOKINETICS
- Challenges of development and implementation of point of care pharmacogenetic testing
- (2016) Susanne B. Haga EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The effect of SNPs in CYP450 in chloroquine/primaquinePlasmodium vivaxmalaria treatment
- (2016) Vinicius A Sortica et al. PHARMACOGENOMICS
- Pharmacogenetics of ribavirin-induced anemia in HCV patients
- (2016) Antonio D'Avolio et al. PHARMACOGENOMICS
- Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis
- (2016) M Maldonado-Montoro et al. PHARMACOGENOMICS JOURNAL
- Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis
- (2016) Mar Maldonado-Montoro et al. PHARMACOLOGICAL RESEARCH
- Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients
- (2015) Sarah Allegra et al. BIOMEDICINE & PHARMACOTHERAPY
- Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency
- (2015) Fay S. Burrows et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis
- (2015) Daniel Pineda-Tenor et al. Journal of Translational Medicine
- Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy)
- (2015) Felix Grassmann et al. BMC Ophthalmology
- Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
- (2015) Ji Yeon Lee et al. Arthritis & Rheumatology
- Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients
- (2014) Elena López Aspiroz et al. Personalized Medicine
- Influence of ABCB1 gene polymorphisms on the pharmacokinetics of azithromycin among healthy Chinese Han ethnic subjects
- (2014) Xiao-Jing He et al. Pharmacological Reports
- Human Leukocyte Antigen Genes and Interferon Beta Preparations Influence Risk of Developing Neutralizing Anti-Drug Antibodies in Multiple Sclerosis
- (2014) Jenny Link et al. PLoS One
- Simultaneous Pharmacogenetics-Based Population Pharmacokinetic Analysis of Darunavir and Ritonavir in HIV-Infected Patients
- (2013) José Moltó et al. CLINICAL PHARMACOKINETICS
- Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children
- (2013) Carolina P. Bellusci et al. GENE
- Reduced Renal Clearance of Cefotaxime in Asians with a Low-Frequency Polymorphism of OAT3 (SLC22A8)
- (2013) Sook Wah Yee et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A formula to estimate the optimal dosage of ribavirin for the treatment of chronic hepatitis C: influence of ITPA polymorphisms
- (2012) Sheeja M Krishnan et al. ANTIVIRAL THERAPY
- Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
- (2012) Monika Rau et al. JOURNAL OF HEPATOLOGY
- Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
- (2011) Yasuhito Tanaka et al. HUMAN MOLECULAR GENETICS
- Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients
- (2011) F Weber et al. PHARMACOGENOMICS JOURNAL
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started